0001209191-16-124799.txt : 20160601 0001209191-16-124799.hdr.sgml : 20160601 20160601185019 ACCESSION NUMBER: 0001209191-16-124799 CONFORMED SUBMISSION TYPE: 3 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20160601 FILED AS OF DATE: 20160601 DATE AS OF CHANGE: 20160601 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Clearside Biomedical, Inc. CENTRAL INDEX KEY: 0001539029 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 452437375 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 1220 OLD ALPHARETTA RD STREET 2: SUITE 300 CITY: ALPHARETTA STATE: GA ZIP: 30005 BUSINESS PHONE: 678-270-4005 MAIL ADDRESS: STREET 1: 1220 OLD ALPHARETTA RD STREET 2: SUITE 300 CITY: ALPHARETTA STATE: GA ZIP: 30005 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: RusnanoMedInvest LLC CENTRAL INDEX KEY: 0001579466 STATE OF INCORPORATION: 1Z FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 3 SEC ACT: 1934 Act SEC FILE NUMBER: 001-37783 FILM NUMBER: 161690543 BUSINESS ADDRESS: STREET 1: SOKOLNICHESKYI VAL STR. OFFICE VII CITY: MOSCOW STATE: 1Z ZIP: 107113 38 BUSINESS PHONE: 074955453912 MAIL ADDRESS: STREET 1: SOKOLNICHESKYI VAL STR. OFFICE VII CITY: MOSCOW STATE: 1Z ZIP: 107113 38 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: RMI Investments S.a.r.l. CENTRAL INDEX KEY: 0001579787 STATE OF INCORPORATION: 1Z FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 3 SEC ACT: 1934 Act SEC FILE NUMBER: 001-37783 FILM NUMBER: 161690544 BUSINESS ADDRESS: STREET 1: 17, RUE DES JARDINIERS CITY: LUXEMBOURG STATE: N4 ZIP: L-1835 BUSINESS PHONE: 79851530799 MAIL ADDRESS: STREET 1: 7, ROBERT STUMPER CITY: GRAND DUCHY STATE: N4 ZIP: L-2557 3 1 doc3.xml FORM 3 SUBMISSION X0206 3 2016-06-01 0 0001539029 Clearside Biomedical, Inc. CLSD 0001579787 RMI Investments S.a.r.l. 7, ROBERT STUMPER GRAND DUCHY N4 L-2557 LUXEMBOURG 0 0 1 0 0001579466 RusnanoMedInvest LLC 44, BLDG. 1, KRASNOBOGATYRSKAYA STREET MOSCOW 1Z 107076 RUSSIAN FEDERATION 0 0 1 0 Common Stock 335769 D Series B Preferred Stock Common Stock 1179398 D The number of shares of common stock reflects a 1-for-2.2 reverse stock split of the Issuer's common stock effected on May 11, 2016. The Reporting Person is a wholly-owned subsidiary of Rusnano MedInvest LLC ("RMI LLC"). RMI LLC is the beneficiary of the Reporting Person. Each share of the Series B Preferred Stock is convertible, at any time, at the holder's election, into 0.454545 shares of the Issuer's common stock. In addition, effective immediately prior to the closing of the Issuer's initial public offering of its common stock, each share of Series B Preferred Stock will automatically convert into 0.454545 shares of the Issuer's common stock. The Series B Preferred Stock has no expiration date. The number of underlying shares of common stock reflects a 1-for-2.2 reverse stock split of the Issuer's common stock effected on May 11, 2016. /s/ Vladimir Gurdus, CEO of RMI Partners, LLC, Managing Company for Rusnano MedInvest, LLC, its Category A Manager 2016-06-01 /s/ Vladimir Gurdus, CEO of RMI Partners, LLC its Managing Company 2016-06-01